p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies
Autor: | Neda Slade, Anđela Horvat, Ana Tadijan, Ignacija Vlašić |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Gene isoform Cancer Research Colorectal cancer p73 isoforms colorectal cancer Review Computational biology Disease Biology medicine.disease_cause 03 medical and health sciences 0302 clinical medicine Transcription (biology) medicine isoform crosstalk Gene RC254-282 Alternative splicing Neoplasms. Tumors. Oncology. Including cancer and carcinogens Promoter medicine.disease 3. Good health 030104 developmental biology p53 isoforms Oncology 030220 oncology & carcinogenesis p53 family Carcinogenesis |
Zdroj: | Cancers Cancers, Vol 13, Iss 2885, p 2885 (2021) |
ISSN: | 2072-6694 |
DOI: | 10.3390/cancers13122885 |
Popis: | Simple Summary The p53 family of proteins comprises p53, p63, and p73, which share high structural and functional similarity. The two distinct promoters of each locus, the alternative splicing, and the alternative translation initiation sites enable the generation of numerous isoforms with different protein-interacting domains and distinct activities. The co-expressed p53/p73 isoforms have significant but distinct roles in carcinogenesis. Their activity is frequently impaired in human tumors including colorectal carcinoma due to dysregulated expression and a dominant-negative effect accomplished by some isoforms and p53 mutants. The interactions between isoforms are particularly important to understand the onset of tumor formation, progression, and therapeutic response. The understanding of the p53/p73 network can contribute to the development of new targeted therapies. Abstract The p53 tumor suppressor protein is crucial for cell growth control and the maintenance of genomic stability. Later discovered, p63 and p73 share structural and functional similarity with p53. To understand the p53 pathways more profoundly, all family members should be considered. Each family member possesses two promoters and alternative translation initiation sites, and they undergo alternative splicing, generating multiple isoforms. The resulting isoforms have important roles in carcinogenesis, while their expression is dysregulated in several human tumors including colorectal carcinoma, which makes them potential targets in cancer treatment. Their activities arise, at least in part, from the ability to form tetramers that bind to specific DNA sequences and activate the transcription of target genes. In this review, we summarize the current understanding of the biological activities and regulation of the p53/p73 isoforms, highlighting their role in colorectal tumorigenesis. The analysis of the expression patterns of the p53/p73 isoforms in human cancers provides an important step in the improvement of cancer therapy. Furthermore, the interactions among the p53 family members which could modulate normal functions of the canonical p53 in tumor tissue are described. Lastly, we emphasize the importance of clinical studies to assess the significance of combining the deregulation of different members of the p53 family to define the outcome of the disease. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |